Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid Nanoparticles For Oral Drug Delivery

S. K. Basha, R. Dhandayuthabani, M. Muzammil, V. S. Kumari
Published 2020 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Solid lipid nanoparticles (SLNs) are an incredibly resourceful drug delivery platform because of its diverse determination and modifiable lipid materials are making the topic exceptionally captivated in the latest year.The network of the SLNs improves drug stability, maintaining a strategic distance from proteolytic debasement after organization, and releasing the drug in a controlled way, which additionally offer a few advantages over ordinary details, including great physical stability, spherical morphology, uniform size, positive zeta potentials, typical high cell penetration efficiency, core–shell pattern and excipients of GRAS status make the SLNs delivery system all the more promising.Subsequently this fresh methodology of solid lipid nanoparticles hold tremendous promise for reaching at the objective of controlled and site exact for both oral and parenteral drug delivery system. The aim of the article is to review the diverse instrumental techniques have been decorated and oral administration of SLNs is logistically reviewed.
This paper references
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
10.3109/03639045.2014.972412
In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
V. Jannin (2015)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1021/BI00460A012
Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings.
O. Hernell (1990)
10.1016/j.jconrel.2009.10.032
Nanosystem drug targeting: Facing up to complex realities.
Pakatip Ruenraroengsak (2010)
10.2147/IJN.S17083
Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles
Shuyu Xie (2011)
10.2147/IJN.S13671
Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles
Solmaz Ghaffari (2010)
10.2147/IJN.S12125
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Z. Urbán-Morlán (2010)
10.1016/J.BBALIP.2007.02.009
Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters.
S. Fernandez (2007)
10.1016/S0939-6411(02)00130-3
Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
M. Schubert (2003)
10.1080/10611860701324698
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery
M. Bondì (2007)
10.33786/JCPR.2011.V01I02.019
Formulation of solid lipid nanoparticles and their applications.
.. A.Krishnasailaja (2011)
10.1016/S0939-6411(03)00040-7
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
10.1016/S0142-9612(01)00362-3
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
10.1016/J.EJPS.2006.01.001
Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
B. Lu (2006)
10.1016/j.addr.2016.03.011
How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?
H. Malhaire (2016)
Block copolymers as drug carriers.
M. Yokoyama (1992)
Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
J. Emami (2015)
10.1016/S0939-6411(01)00157-6
Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.
M. Sznitowska (2001)
10.22270/JDDT.V9I2.2461
Preparation of solid lipid nanoparticles through various methods using different precursors
R. Singh (2019)
10.1016/J.EJPB.2007.09.009
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
S. Motwani (2008)
10.1081/RRS-100107429
LIPID-BASED FORMULATIONS FOR ORAL ADMINISTRATION: OPPORTUNITIES FOR BIOAVAILABILITY ENHANCEMENT AND LIPOPROTEIN TARGETING OF LIPOPHILIC DRUGS
C. J. Porter (2001)
10.1146/ANNUREV.PH.45.030183.003251
Lipid digestion and absorption.
M. Carey (1983)
10.1016/J.JCONREL.2004.01.005
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
V. Venkateswarlu (2004)
10.1016/J.ADDR.2007.04.010
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
P. Chattopadhyay (2007)
10.1248/CPB.49.1444
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.
D. Chen (2001)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
R. Parhi (2010)
10.3109/10717544.2015.1039666
Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats
M. J. Ansari (2016)
10.1002/JPS.20555
Drug encapsulation using supercritical fluid extraction of emulsions.
P. Chattopadhyay (2006)
10.1073/PNAS.74.11.4991
Fate of lipid vesicles in vivo: a gamma-ray perturbed angular correlation study.
K. J. Hwang (1977)
10.1080/10717540701203034
Preparation and Characterization of Solid Lipid Nanoparticles Containing Silibinin
J. Zhang (2007)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.1208/s12249-009-9199-0
Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery
M. Bhalekar (2009)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.2147/IJN.S33682
Development of terbinafine solid lipid nanoparticles as a topical delivery system
Y. Chen (2012)
10.1023/A:1015874121860
Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy
T. Eldem (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar